Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type 5 cyclic nucleotide phosphodiesterase (PDE5) is a key regulator of intracellular cGMP levels with major roles in vascular tone regulation and reproductive physiology. It serves as an important drug target due to its tissue distribution profile and regulatory mechanisms that allow selective pharmacological intervention without widespread systemic effects when properly targeted.
Selective inhibition of PDE5, preventing the breakdown of cGMP
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type 5 Cyclic Nucleotide Phosphodiesterase (PDE5).